PortalPublikationenIn-vivo-validation of a cardiovascular risk prediction tool:...

In-vivo-validation of a cardiovascular risk prediction tool: the arriba-pro study.

Standard

In-vivo-validation of a cardiovascular risk prediction tool: the arriba-pro study. / Diener, Annette; Celemín-Heinrich, Salomé; Wegscheider, Karl; Kolpatzik, Kai; Tomaschko, Katrin; Altiner, Attila; Donner-Banzhoff, Norbert; Haasenritter, Jörg.

in: BMC FAM PRACT, Jahrgang 14, 2013, S. 13.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Diener, A, Celemín-Heinrich, S, Wegscheider, K, Kolpatzik, K, Tomaschko, K, Altiner, A, Donner-Banzhoff, N & Haasenritter, J 2013, 'In-vivo-validation of a cardiovascular risk prediction tool: the arriba-pro study.', BMC FAM PRACT, Jg. 14, S. 13. https://doi.org/10.1186/1471-2296-14-13

APA

Diener, A., Celemín-Heinrich, S., Wegscheider, K., Kolpatzik, K., Tomaschko, K., Altiner, A., Donner-Banzhoff, N., & Haasenritter, J. (2013). In-vivo-validation of a cardiovascular risk prediction tool: the arriba-pro study. BMC FAM PRACT, 14, 13. https://doi.org/10.1186/1471-2296-14-13

Vancouver

Diener A, Celemín-Heinrich S, Wegscheider K, Kolpatzik K, Tomaschko K, Altiner A et al. In-vivo-validation of a cardiovascular risk prediction tool: the arriba-pro study. BMC FAM PRACT. 2013;14:13. https://doi.org/10.1186/1471-2296-14-13

Bibtex

@article{89d0dd11c52d4623954ac1b5971082da,
title = "In-vivo-validation of a cardiovascular risk prediction tool: the arriba-pro study.",
abstract = "Calculation of individual risk is the cornerstone of effective cardiovascular prevention. arriba is a software to estimate the individual risk to suffer a cardiovascular event in 10 years. Prognosis and the absolute effects of pharmacological and lifestyle interventions help the patient make a well-informed decision. The risk calculation algorithm currently used in arriba is based on the Framingham risk algorithm calibrated to the German setting. The objective of this study is to evaluate and adapt the algorithm for the target population in primary care in Germany.",
keywords = "Germany, Humans, Risk Assessment, Research Design, *Software, *Primary Health Care, *Algorithms, Cardiovascular Diseases/etiology/*prevention & control, *Primary Prevention, Germany, Humans, Risk Assessment, Research Design, *Software, *Primary Health Care, *Algorithms, Cardiovascular Diseases/etiology/*prevention & control, *Primary Prevention",
author = "Annette Diener and Salom{\'e} Celem{\'i}n-Heinrich and Karl Wegscheider and Kai Kolpatzik and Katrin Tomaschko and Attila Altiner and Norbert Donner-Banzhoff and J{\"o}rg Haasenritter",
year = "2013",
doi = "10.1186/1471-2296-14-13",
language = "English",
volume = "14",
pages = "13",
journal = "BMC PRIM CARE",
issn = "1471-2296",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - In-vivo-validation of a cardiovascular risk prediction tool: the arriba-pro study.

AU - Diener, Annette

AU - Celemín-Heinrich, Salomé

AU - Wegscheider, Karl

AU - Kolpatzik, Kai

AU - Tomaschko, Katrin

AU - Altiner, Attila

AU - Donner-Banzhoff, Norbert

AU - Haasenritter, Jörg

PY - 2013

Y1 - 2013

N2 - Calculation of individual risk is the cornerstone of effective cardiovascular prevention. arriba is a software to estimate the individual risk to suffer a cardiovascular event in 10 years. Prognosis and the absolute effects of pharmacological and lifestyle interventions help the patient make a well-informed decision. The risk calculation algorithm currently used in arriba is based on the Framingham risk algorithm calibrated to the German setting. The objective of this study is to evaluate and adapt the algorithm for the target population in primary care in Germany.

AB - Calculation of individual risk is the cornerstone of effective cardiovascular prevention. arriba is a software to estimate the individual risk to suffer a cardiovascular event in 10 years. Prognosis and the absolute effects of pharmacological and lifestyle interventions help the patient make a well-informed decision. The risk calculation algorithm currently used in arriba is based on the Framingham risk algorithm calibrated to the German setting. The objective of this study is to evaluate and adapt the algorithm for the target population in primary care in Germany.

KW - Germany

KW - Humans

KW - Risk Assessment

KW - Research Design

KW - Software

KW - Primary Health Care

KW - Algorithms

KW - Cardiovascular Diseases/etiology/prevention & control

KW - Primary Prevention

KW - Germany

KW - Humans

KW - Risk Assessment

KW - Research Design

KW - Software

KW - Primary Health Care

KW - Algorithms

KW - Cardiovascular Diseases/etiology/prevention & control

KW - Primary Prevention

U2 - 10.1186/1471-2296-14-13

DO - 10.1186/1471-2296-14-13

M3 - SCORING: Journal article

VL - 14

SP - 13

JO - BMC PRIM CARE

JF - BMC PRIM CARE

SN - 1471-2296

ER -